Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ramipril × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Cisplatin 609 Carboplatin 504 Paclitaxel 487 Cyclophosphamide 452 Radiotherapy 451 Docetaxel 411 Fluorouracil 382 Gemcitabine 362 Doxorubicin 340 Capecitabine 315 Dexamethasone 282 Oxaliplatin 245 Vincristine 234 Leucovorin 233 pembrolizumab 232 Etoposide 230 Bevacizumab 227 Rituximab 207 Prednisone 196 Pemetrexed 180 Cytarabine 179 Drug Therapy 171 Methotrexate 151 Trastuzumab 147 Irinotecan 139 Lenalidomide 123 Filgrastim 118 Nivolumab 112 Chemotherapy, Adjuvant 111 Tamoxifen 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236806 2022-02-01

SAFE

Azienda Ospedaliero-Universitaria Careggi

Phase 3 Unknown

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡